FR2340092A2 - Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament - Google Patents
Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicamentInfo
- Publication number
- FR2340092A2 FR2340092A2 FR7603458A FR7603458A FR2340092A2 FR 2340092 A2 FR2340092 A2 FR 2340092A2 FR 7603458 A FR7603458 A FR 7603458A FR 7603458 A FR7603458 A FR 7603458A FR 2340092 A2 FR2340092 A2 FR 2340092A2
- Authority
- FR
- France
- Prior art keywords
- quinoline
- thiazolyl
- carboxylic acid
- corresp
- prepd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229950003476 aminothiazole Drugs 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 title 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 title 1
- CYWRIXWCXYMYGJ-UHFFFAOYSA-N 4-oxo-n-(1,3-thiazol-2-yl)-8-(trifluoromethoxy)-1h-quinoline-3-carboxamide Chemical compound C1=NC2=C(OC(F)(F)F)C=CC=C2C(O)=C1C(=O)NC1=NC=CS1 CYWRIXWCXYMYGJ-UHFFFAOYSA-N 0.000 abstract 2
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 abstract 1
- KDQHQWQHFIKIIP-UHFFFAOYSA-N 4-oxo-8-(trifluoromethylsulfanyl)-1h-quinoline-3-carbonyl chloride Chemical compound N1C=C(C(Cl)=O)C(=O)C2=C1C(SC(F)(F)F)=CC=C2 KDQHQWQHFIKIIP-UHFFFAOYSA-N 0.000 abstract 1
- IQXXUFRPMHAJBM-UHFFFAOYSA-N 4-oxo-n-(1,3-thiazol-2-yl)-8-(trifluoromethylsulfanyl)-1h-quinoline-3-carboxamide Chemical compound C1=NC2=C(SC(F)(F)F)C=CC=C2C(O)=C1C(=O)NC1=NC=CS1 IQXXUFRPMHAJBM-UHFFFAOYSA-N 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7603458A FR2340092A2 (fr) | 1976-02-09 | 1976-02-09 | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7603458A FR2340092A2 (fr) | 1976-02-09 | 1976-02-09 | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2340092A2 true FR2340092A2 (fr) | 1977-09-02 |
| FR2340092B2 FR2340092B2 (enExample) | 1982-01-08 |
Family
ID=9168887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7603458A Granted FR2340092A2 (fr) | 1976-02-09 | 1976-02-09 | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2340092A2 (enExample) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2435469A1 (fr) * | 1978-08-11 | 1980-04-04 | Squibb & Sons Inc | Derives mercaptoacyles de prolines substituees a action hypotensive |
| FR2655344A1 (fr) * | 1989-12-06 | 1991-06-07 | Sanofi Sa | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
| US5189049A (en) * | 1989-12-06 | 1993-02-23 | Sanofi | Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| US7495103B2 (en) | 2004-06-24 | 2009-02-24 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| US9139530B2 (en) | 2005-12-28 | 2015-09-22 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| US9751839B2 (en) | 2009-03-20 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| US10272046B2 (en) | 2012-02-27 | 2019-04-30 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US10646481B2 (en) | 2008-08-13 | 2020-05-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
-
1976
- 1976-02-09 FR FR7603458A patent/FR2340092A2/fr active Granted
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2435469A1 (fr) * | 1978-08-11 | 1980-04-04 | Squibb & Sons Inc | Derives mercaptoacyles de prolines substituees a action hypotensive |
| FR2655344A1 (fr) * | 1989-12-06 | 1991-06-07 | Sanofi Sa | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
| US5189049A (en) * | 1989-12-06 | 1993-02-23 | Sanofi | Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| USRE37094E1 (en) | 1989-12-06 | 2001-03-13 | Sanofi | Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| US10662192B2 (en) | 2004-06-24 | 2020-05-26 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US7495103B2 (en) | 2004-06-24 | 2009-02-24 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US8324242B2 (en) | 2004-06-24 | 2012-12-04 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| US8614327B2 (en) | 2004-06-24 | 2013-12-24 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US8629162B2 (en) | 2004-06-24 | 2014-01-14 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US8741925B2 (en) | 2004-06-24 | 2014-06-03 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US8101767B2 (en) | 2004-06-24 | 2012-01-24 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US9090619B2 (en) | 2004-06-24 | 2015-07-28 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US11291662B2 (en) | 2005-12-28 | 2022-04-05 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9670163B2 (en) | 2005-12-28 | 2017-06-06 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9139530B2 (en) | 2005-12-28 | 2015-09-22 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US10537565B2 (en) | 2005-12-28 | 2020-01-21 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9931334B2 (en) | 2005-12-28 | 2018-04-03 | Vertex Pharmaceuticals Incorporated | Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US10646481B2 (en) | 2008-08-13 | 2020-05-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11564916B2 (en) | 2008-08-13 | 2023-01-31 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US9751839B2 (en) | 2009-03-20 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| US10272046B2 (en) | 2012-02-27 | 2019-04-30 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11147770B2 (en) | 2012-02-27 | 2021-10-19 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11752106B2 (en) | 2012-02-27 | 2023-09-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US12214083B2 (en) | 2012-02-27 | 2025-02-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2340092B2 (enExample) | 1982-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1209254B (it) | Procedimento per rilevare perdite in condutture e apparecchiature per l'attuazione del procedimento. | |
| JPS5266551A (en) | Stabilizer for plastics | |
| FR2340092A2 (fr) | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament | |
| NO145397C (no) | Agglomerat av poroes termoplast med antiakustiske egenskaper og fremgangsmaate for dets fremstilling | |
| DK157724C (da) | Dipeptidsoedemiddel-metal-kompleks og dets anvendelse | |
| BR7701233A (pt) | Processo e aparelho de conduzir correntes de ar | |
| JPS5264580A (en) | Sequence controller | |
| JPS5240903A (en) | Voice compound equipment | |
| JPS5233143A (en) | Compressive molten bath method by industive heat way | |
| JPS5234644A (en) | Folding-type computer | |
| JPS51126070A (en) | Weber treatment equipment | |
| JPS5223236A (en) | Tag comupter | |
| NL7900079A (nl) | Nieuwe gesubstitueerde 1,4-cyclohexadieencarbonzuren en derivaten daarvan. | |
| IT8020744A0 (it) | Ugello per l'impiego in altoforni. | |
| JPS51146777A (en) | Prevention of white incinerator fume | |
| ZA764557B (en) | 6,11-dihydro-11-oxodibenz7b,e)oxepinalkanoic acids and esters thereof | |
| AU3452758A (en) | r "Improvements in or relating tothe recovery of heat fromthe fumes of industrial furnaces | |
| JPS5265633A (en) | End controller | |
| JPS52125247A (en) | Common data selecting unit | |
| Romany | Absenteeism among clerical workers in Trinidad an investigation of different types of absence as influenced by personal value, attitudinal and biographical predictors. | |
| Azbukin et al. | Features of the Corrosion-Mechanical Damage of Austenitic Steels in Static and Cyclic Loading | |
| Richardson | The poetry and the social vision of FR Scott. | |
| IT7928000A0 (it) | Prodotto per il trattamento di infezioni virali dell'occhio e di altri organi. | |
| CA636391A (en) | Surgeons' gloves and method of making the same | |
| CA606440A (en) | N,n'-diglycidylpiperazine and method of making it |